MARKET

KRYS

KRYS

Krystal Biotech
NASDAQ
371.58
-0.09
-0.02%
Pre Market: 374.36 +2.78 +0.75% 07:00 07/02 EDT
OPEN
370.57
PREV CLOSE
371.67
HIGH
377.31
LOW
363.28
VOLUME
8
TURNOVER
0
52 WEEK HIGH
382.54
52 WEEK LOW
130.50
MARKET CAP
10.95B
P/E (TTM)
49.69
1D
5D
1M
3M
1Y
5Y
1D
FDA PreCheck Could Speed Up These 3 U.S. Biopharma Stocks
Simply Wall St · 2d ago
Weekly Report: what happened at KRYS last week (0622-0626)?
Weekly Report · 3d ago
Krystal Biotech EVP, General Counsel John C. Thomas disposes of USD 347,270 in common shares
PUBT · 5d ago
Krystal Biotech (KRYS) Rallies On Pipeline Optimism, Is The Stock Already Pricey?
Simply Wall St · 6d ago
10 large and mega-cap U.S. healthcare stocks with the strongest momentum grades
Seeking Alpha · 06/24 13:35
Krystal Biotech (KRYS) Is Up 7.2% After Institutional Ownership Surges To Sector-Leading Levels
Simply Wall St · 06/22 18:27
As AbbVie eyes Apogee, these biotech stocks earn the highest Quant ratings
Seeking Alpha · 06/22 13:32
Weekly Report: what happened at KRYS last week (0615-0619)?
Weekly Report · 06/22 10:21
More
About KRYS
Krystal Biotech, Inc. is an integrated, commercial-stage biotechnology company. The Company is focused on the discovery, development, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Its product candidates in various stages of clinical and preclinical development include KB407, KB408, KB707, KB105, KB801, KB803, KB304 and KB301. Its commercial product, VYJUVEK, is a redosable gene therapy, and a genetic medicine approved in the United States and Europe for the treatment of dystrophic epidermolysis bullosa. KB407 is being developed for the treatment of Cystic Fibrosis. KB408 is being developed for the treatment of Alpha-1 Antitrypsin Deficiency, a rare lung disease. KB707 is being developed for the treatment of solid tumors. KB105 is being developed for TGM1-Deficient Autosomal Recessive Congenital Ichthyosis. KB803 is a redosable eye drop formulation of B-VEC, designed for the treatment of ocular complications.

Webull offers Krystal Biotech Inc stock information, including NASDAQ: KRYS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KRYS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KRYS stock methods without spending real money on the virtual paper trading platform.